Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
That persistence deserves a real answer not another round of "try stretching and come back in six weeks." BPC-157 may or may not be the right tool for your specific situation
Hypoxia induces drug resistance in colorectal cancer through the HIF-1alpha/miR-338-5p/IL-6 feedback loop
Research Stage: Tirzepatide is approved
One published case series (N=14 patients, mixed athletic backgrounds) noted that 11 of 14 participants reported reduced DOMS duration from an average of 72 hours to approximately 36 hours, though this was self-reported and uncontrolled
In a randomized, double-blind trial where women applied GHK-Cu encapsulated in a nano-lipid carrier twice daily for 8 weeks, the treatment group saw significant improvements in wrinkle depth and volume with no serious adverse events
Our results indicated that neither GHK nor GHK-Cu showed cytotoxic activity at the range of concentrations tested while CuCl 2 and Cu(OAc) 2 showed substantial cytotoxicity to the HaCaT cells at the highest concentration assayed, i.e., at 5800 M, after 30 mins treatment
